TY  - GEN
AU  - Ohnuma,Hiroyuki
AU  - Sato,Yasushi
AU  - Hayasaka,Naotaka
AU  - Matsuno,Teppei
AU  - Fujita,Chisa
AU  - Sato,Masanori
AU  - Osuga,Takahiro
AU  - Hirakawa,Masahiro
AU  - Miyanishi,Koji
AU  - Sagawa,Tamotsu
AU  - Fujikawa,Koshi
AU  - Ohi,Motoh
AU  - Okagawa,Yutaka
AU  - Tsuji,Yasushi
AU  - Hirayama,Michiaki
AU  - Ito,Tatsuya
AU  - Nobuoka,Takayuki
AU  - Takemasa,Ichiro
AU  - Kobune,Masayoshi
AU  - Kato,Junji
TI  - Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study
SN  - 1349-7006
PY  - 2018///1119
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Carcinoma, Squamous Cell
KW  - drug therapy
KW  - Docetaxel
KW  - Drug Administration Schedule
KW  - Esophageal Neoplasms
KW  - Esophageal Squamous Cell Carcinoma
KW  - Esophagectomy
KW  - Feasibility Studies
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Japan
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Organoplatinum Compounds
KW  - Survival Analysis
KW  - Taxoids
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1111/cas.13772
ER  -